Accelerating Drug Discovery using AI/ML
pepAI predicts novel and diverse molecules accurately and accelerates the pre-clinical discovery
a)Ultra large virtual screening b)Agnostic to therapies and targets(human, bacterial, viral) c)De-novo molecules – novel IP with desired properties
- Antimicrobial compound/strategy
- Co-develop, Outsource, Joint Venture
- OTHER / NA
Infectious disease area:
Biotech or Pharma companies with strong biology capabilites seeking partners for HIT identification, Lead generation and lead optimization of novel chemical scaffolds for their protein targets.
Peptris is an AI/ML company creating a versatile AI platform (pepAI) to enhance efficiencies by 10x or more across the drug discovery cascade.
pepAI can scan over a 100Million molecules for diverse applications including – activity prediction on mutated protein in drug resistant organisms thus accelerating drug discovery for AMR